Field Medical Reports 12-Month Field PULSE Trial Results
Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...
Rehovot, Israel, September 18, 2026 CardiaCare, a medical device company developing wearable technology for cardiac arrhythmias, has announced the...
Singapore and New York, September 16, 2026 KELLS, Inc. has announced that its KELLS AI Dental Scan has been...
PONTE VEDRA, Fla. — September 17, 2026 Treace Medical Concepts announced clinical results from three studies evaluating its Lapiplasty®,...
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
Valencia, California, USA, September 16, 2026 SetPoint Medical announced that Oregon Health & Science University (OHSU) has become the...
Boston, Massachusetts, U.S., September 15, 2026 ReEmerge, Inc. has emerged from stealth with an oversubscribed $37 million Series A...
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
Caesarea, Israel, September 15, 2026 Nitinotes has announced the completion of the first EASEâ„¢ clinical trial procedures at Fondazione...
VAUGHAN, Ontario — September 11, 2026 Bausch + Lomb Corporation announced that its next-generation SeeLyra™ femtosecond laser has received...
